Patents Assigned to CMP Development LLC
-
Patent number: 11491166Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.Type: GrantFiled: December 4, 2020Date of Patent: November 8, 2022Assignee: CMP DEVELOPMENT LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Publication number: 20220313709Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.Type: ApplicationFiled: June 16, 2022Publication date: October 6, 2022Applicant: CMP DEVELOPMENT LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Publication number: 20220305032Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.Type: ApplicationFiled: June 16, 2022Publication date: September 29, 2022Applicant: CMP DEVELOPMENT LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Patent number: 11395828Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.Type: GrantFiled: July 23, 2021Date of Patent: July 26, 2022Assignee: CMP DEVELOPMENT LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Patent number: 11389461Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.Type: GrantFiled: July 23, 2021Date of Patent: July 19, 2022Assignee: CMP DEVELOPMENT LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Publication number: 20210353646Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.Type: ApplicationFiled: July 23, 2021Publication date: November 18, 2021Applicant: CMP DEVELOPMENT LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Publication number: 20210346404Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.Type: ApplicationFiled: July 23, 2021Publication date: November 11, 2021Applicant: CMP DEVELOPMENT LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Publication number: 20210085694Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.Type: ApplicationFiled: December 4, 2020Publication date: March 25, 2021Applicant: CMP DEVELOPMENT LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Patent number: 10888570Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.Type: GrantFiled: May 19, 2020Date of Patent: January 12, 2021Assignee: CMP DEVELOPMENT LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Publication number: 20200276212Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.Type: ApplicationFiled: May 19, 2020Publication date: September 3, 2020Applicant: CMP DEVELOPMENT LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Patent number: 10660907Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.Type: GrantFiled: March 19, 2020Date of Patent: May 26, 2020Assignee: CMP Development LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Publication number: 20200147109Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.Type: ApplicationFiled: November 13, 2019Publication date: May 14, 2020Applicant: CMP DEVELOPMENT LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Patent number: 10632150Abstract: Disclosed herein is a sterile composition for injection comprised of potassium phosphates having no visible particulate. Also disclosed herein is a manufacturing process for the sterile composition and its use.Type: GrantFiled: April 19, 2019Date of Patent: April 28, 2020Assignee: CMP Development LLCInventors: H. Greg Thomas, Richard LeVasseur, Jeffrey S. Kiel, Anthony Reid Pipho
-
Patent number: 10624906Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.Type: GrantFiled: November 13, 2019Date of Patent: April 21, 2020Assignee: CMP Development LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Patent number: 10493083Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.Type: GrantFiled: July 31, 2017Date of Patent: December 3, 2019Assignee: CMP Development LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Publication number: 20170326158Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.Type: ApplicationFiled: July 31, 2017Publication date: November 16, 2017Applicant: CMP Development LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Patent number: 9757394Abstract: Disclosed herein is a pharmaceutical composition, comprising: (a) spironolactone; (b) a xanthan gum; (c) an anti-foaming agent; (d) a preservative; (f) a dispersing agent; (g) a sweetening agent; (h) a flavoring agent; (i) optionally a buffer to maintain the pH of the pharmaceutical composition within a range described herein; and (j) a sufficient amount of a water vehicle.Type: GrantFiled: October 28, 2016Date of Patent: September 12, 2017Assignee: CMP DEVELOPMENT LLCInventors: Anthony Pipho, Michael Paul DeHart
-
Publication number: 20170119796Abstract: Disclosed herein is a pharmaceutical composition, comprising: (a) spironolactone; (b) a xanthan gum; (c) an anti-foaming agent; (d) a preservative; (f) a dispersing agent; (g) a sweetening agent; (h) a flavoring agent; (i) optionally a buffer to maintain the pH of the pharmaceutical composition within a range described herein; and (j) a sufficient amount of a water vehicle.Type: ApplicationFiled: October 28, 2016Publication date: May 4, 2017Applicant: CMP Development LLCInventors: Anthony Pipho, Michael Paul DeHart